Seattle Genetics Inc (SGEN)

Add to Watchlists
Create an Alert
69.16 +1.13  +1.66% NASDAQ May 24, 16:59 Delayed 2m USD
View Full Chart
SGEN Price Chart
View All Events

SGEN Events

Date Type Description
07/26/2019 16:30 EDT Misc Seattle Genetics Inc Second Quarter Earnings Conference Call in 2019
07/26/2019 Earnings Seattle Genetics Inc Second Quarter Earnings in 2019 Release
05/20/2019 Misc Seattle Genetics Inc Annual General Meeting in 2018
04/25/2019 16:30 EDT Misc Seattle Genetics Inc First Quarter Earnings Conference Call in 2019
04/25/2019 Earnings Seattle Genetics Inc First Quarter Earnings in 2019 Release
02/07/2019 16:30 EST Misc Seattle Genetics Inc Fourth Quarter Earnings Conference Call in 2018
02/07/2019 Earnings Seattle Genetics Inc Fourth Quarter Earnings in 2018 Release
02/07/2019 Misc Seattle Genetics Inc Annual Report in 2018
10/25/2018 16:30 EDT Misc Seattle Genetics Inc Third Quarter Earnings Conference Call in 2018
10/25/2018 Earnings Seattle Genetics Inc Third Quarter Earnings Results in 2018
View All Performance Charts

SGEN Total Returns Comparison

Advertisement

SGEN One Page Reports

Edit

Profile

  • URL: http://www.seattlegenetics.com
  • Investor Relations URL: http://investor.seattlegenetics.com/phoenix.zhtml?c=124860&p=irol-IRHome
  • HQ State/Province: Washington
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Jul. 26, 2019
  • Last Earnings Release: Apr. 25, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Seattle Genetics is a biotech firm focused on the development of monoclonal antibody-based therapies. The company's lead product, Adcetris, has received approval for advanced frontline, relapsed/refractory and post-consolidation Hodgkin lymphoma, anaplastic large-cell lymphoma, and two other subtypes of cutaneous T-cell lymphoma. The company has several other early-stage programs in trials. Seattle Genetics also licenses its antibody-drug conjugate technology to a number of leading biotechnology and pharmaceutical companies.

SGEN Comparables

Edit

Excel Add-In Codes

  • Name: =YCI("SGEN","name")
  • Description: =YCI("SGEN","description")
  • Sector: =YCI("SGEN","sector")
  • Industry: =YCI("SGEN","industry")
  • Est. Current Fiscal Year End: =YCI("SGEN","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.